(Q38161536)

30 August 2017

title

Myeloid-derived suppressor cells in glioma (English)

1 reference

30 August 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Masoud Mirghorbani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Stefaan Van Gool

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

12 November 2013

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

1395-1406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

Progenitor cells and glioma formation

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Brain tumor survival: results from the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Epidemiology and etiology of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Present and potential future issues in glioblastoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Human glioma immunobiology in vitro: implications for immunogene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Treg infiltration in glioma: a hurdle for antiglioma immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Microglia only weakly present glioma antigen to cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Antigen-presenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Microglial/macrophage expression of interleukin 10 in human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Expression of Fas ligand by microglia: possible role in glioma immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Regulation of T cell receptor CD3zeta chain expression by L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Control of Bcl-2 expression by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Physiological functions of thioredoxin and thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Inhibition of MHC II gene transcription by nitric oxide and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Reciprocal relationship between myeloid-derived suppressor cells and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Immune defects observed in patients with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Regulation of NK cell function by human granulocyte arginase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Targeting natural killer cells and natural killer T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

S100A8 and S100A9 in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Arginase and vascular aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Transport and utilization of arginine and arginine-containing peptides by rat alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Long-term anti-inflammatory and antihistamine medication use and adult glioma risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

L-arginine availability regulates T-lymphocyte cell-cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Transforming growth factor beta (TGF-beta) and inflammation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Selective expression of interleukin-10 gene within glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Glioma-associated cancer-initiating cells induce immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.857603

10.1586/14737175.2013.857603

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24215283%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference